About Indinex Private Limited
Data last updated:
Indinex Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 October 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2012PTC236895. Its GSTIN is 27AADCI1239F1ZU (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹23.81 Lakh. It is led by directors Rajesh Annapandi Nadar and Sanney Umashankar Sharma.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Unit No. F – 1 First Floor Fantasia Business Park Plot No. 47 Sector No 30A Vashi, Navi Mumbai, Maharashtra, India – 400703.
As per the financials filed for FY 2018, the company reported a revenue of ₹2.21 Cr, a decline of 81% compared to the previous year. For the same year it recorded a net loss of ₹16.1 Lakh (net margin -7.3%) and EBITDA of -₹3.18 Lakh (EBITDA margin -1.4%).
As per MCA filings, the company has satisfied charges of ₹2.45 Cr on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website indinex.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUnit No. F – 1 First Floor Fantasia Business Park Plot No. 47 Sector No 30A Vashi, Navi Mumbai, Maharashtra, India – 400703
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Indinex Private Limited
The main business activity of Indinex is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Indinex Private Limited FY 2018 filings available
Indinex Private Limited reported revenue of ₹2.21 Cr (down 81% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR) of Indinex Private Limited
Revenue fell 81% in the latest year. EBITDA fell 135% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Indinex Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | ₹2.21 Cr | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.18 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹16.1 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Indinex Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -1.4% | •••• | •••• | •••• |
| Net Profit Margin | -7.3% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Indinex are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Indinex Private Limited
Indinex Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Upthink Solutions Private Limited | ₹2.22 Cr (FY 2025) | •••• | •••• | 84.0% | •••• | Hyderabad, Telangana, India |
| Keron Lifesciences Private Limited | ₹2.21 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Dehradun, Uttarakhand, India |
| Prevoir Healthcare Private Limited | ₹2.21 Cr (FY 2025) | •••• | •••• | 199.0% | •••• | Pune, Maharashtra, India |
| Manmohini Pharmaceuticals Private Limited | ₹2.21 Cr (FY 2025) | •••• | •••• | •••• | Murshidabad, West Bengal, India | |
| Mendel Pharma Private Limited | ₹2.21 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| Indinex Private Limited this company | ₹2.21 Cr (FY 2018) | •••• | •••• | -81.0% | •••• | Navi Mumbai, Maharashtra, India |
| Scion Pharma Private Limited | ₹2.21 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Gandhinagar, Gujarat, India |
| Cinicot Private Limited | ₹2.21 Cr (FY 2024) | •••• | •••• | -82.0% | •••• | Mohali, Punjab, India |
| Tulip Formulations Private Limited | ₹2.21 Cr (FY 2015) | •••• | •••• | 58.0% | •••• | Indora, Himachal Pradesh, India |
| Esvy Life Sciences Private Limited | ₹2.21 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Begumpet, Hyderabad, Telangana, India |
| Ciel Pharma Private Limited | ₹2.2 Cr (FY 2022) | •••• | •••• | 20.0% | •••• | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Indinex by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Indinex Private Limited
Indinex Private Limited is audited by ARUN JAMUNA & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ARUN JAMUNA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Indinex Private Limited
Indinex has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Annapandi Nadar | Additional Director | 16 Aug 2021 | 5 Years 1 Months | Current |
| Sanney Umashankar Sharma Also directs: Axel Nikea LLP, Aadikrishi Innovations LLP | Additional Director | 22 Jul 2021 | 5 Years 2 Months | Current |
Ownership and Shareholding of Indinex Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Indinex Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2015 | Bank of India | ₹2.45 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Indinex Private Limited
Employment history and EPFO contributions of people linked to Indinex.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Indinex Private Limited
Indinex Private Limited has 16 board changes on record since 2012: 9 appointments and 7 cessations. The latest: Mary Agnes Dsilwa ceased to be Director on 16 Aug 2021.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Indinex Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Indinex Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Indinex Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Indinex Private Limited
Indinex has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCI1239F1ZU | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Indinex Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indinex Private Limited
Indinex is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 October 2012 (14+ years old) and is registered under CIN U24100MH2012PTC236895.
Indinex reported revenue of ₹2.21 Cr for FY 2018 (down 81% YoY).
Indinex has 2 current directors:
- Rajesh Annapandi Nadar - Additional Director
- Sanney Umashankar Sharma - Additional Director
Indinex reported a net loss of ₹16.1 Lakh (net margin -7.3%) and EBITDA of -₹3.18 Lakh (EBITDA margin -1.4%) for FY 2018, as per its filed financial statements.
The GSTIN of Indinex is 27AADCI1239F1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Indinex is U24100MH2012PTC236895. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indinex was incorporated on 17 October 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Indinex by revenue are Upthink Solutions Private Limited, Keron Lifesciences Private Limited, Prevoir Healthcare Private Limited, Manmohini Pharmaceuticals Private Limited, Mendel Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Mary Agnes Dsilwa ceased to be Director on 16 Aug 2021. Rajesh Annapandi Nadar was appointed as Additional Director on 16 Aug 2021. Prashant Pandey ceased to be Director on 09 Aug 2021. Indinex has 16 board changes on record in total.
Indinex can be reached through the website indinex.in. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Indinex is at Unit No. F – 1 First Floor Fantasia Business Park Plot No. 47 Sector No 30A Vashi, Navi Mumbai, Maharashtra, India – 400703.